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ISG15 facilitates cellular antiviral response to
dengue and west nile virus infection in vitro
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Abstract
Background: Dengue virus (DENV) and West Nile virus (WNV), close siblings of the Flaviviridae family, are the
causative agents of Dengue hemorraghic shock or West Nile meningoencephalitis respectively. Vaccines against
these two flaviviruses are currently unavailable. Interferon- Stimulated Gene 15 (ISG15), encoding an ubiquitin-like
protein, is significantly induced by type I interferons or viral infections. Its roles in viral infections, however, vary
with viruses, being either anti- or pro-viral. The exact roles of ISG15 in DENV and WNV infections remain unknown.
In the current study, we evaluated the relevancies of ISG15 to DENV and WNV infection of a mouse macrophage
cell line RAW264.7.
Findings: Quantitative PCR showed that mouse Isg15 was dramatically induced in DENV or WNV- infected
RAW264.7 cells compared with non-infected cells. Isg15 and two other Jak-Stat related genes, Socs1 and Socs3,
were silenced using siRNA mediated RNA interference. The intracellular DENV and WNV loads, as determined by
quantitative PCR, were significantly higher in Isg15 silenced cells than control cells. The expression levels of
interferon beta 1 (Ifnb1) were increased significantly in Isg15, Socs1 or Socs3 siRNA treated cells. Further
investigation indicated that protein modification by ISG15, so called ISGylation, was significantly enhanced in
DENV-infected cells compared to that in non-infected cells.
Conclusions: These findings suggest that ISG15 plays an anti-DENV/WNV function via protein ISGylation.
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Findings
Dengue virus (DENV) and West Nile virus (WNV) are
two major flaviviruses that can infect human via mos-
quito bites [1]. Both viruses are (+) sense single strand
RNA viruses and replicate in the cytoplasm of their host
cells. DENV infection causes Dengue fever (DF) or Den-
gue hemorrhagic fever (DHF), and the latter may lead to
death of the patient [2]. WNV is a re-emerging zoonotic
pathogen of medical importance. In humans, WNV
infection may cause life-threatening meningoencephalitis
or long-term neurologic sequelae [3]. Vaccines against
both DENV and WNV are currently not available, thus
much efforts are needed to elucidate the mammalian
host anti-viral mechanisms against these two flaviviruses
in vitro and in vivo [1-3].
ISG15 is one of the first identified Interferon-Stimu-
lated- Genes (ISGs). The expression of ISG15 can be
induced by type I interferons (IFNs), viral infections and
LPS, suggesting that ISG15 is a broad spectrum of stress
response gene [4,5]. The protein product of ISG15
shows a significant sequence homology to ubiqutin, and
this protein can conjugate to numerous cellular proteins
via isopeptide bonds. This kind of protein modification
is called ISGylation, which also utilizes a three step reac-
tion similar to protein ubiquitination. The specific
enzymes for ISGylation are UBE1L (E1), UBCH8 (E2)
and HERC5 (E3), respectively. Like ubquitination, ISGy-
lation is reversible, mediated by deISGylation enzymes,
such as UBP43. Notably, expression of UBE1L, UBCH8,
HERC5, and UBP43 is also induced by IFN [4-7]. Till
now, more than 200 cellular proteins were identified as
the substrates of ISG15, while the functional conse-
quences of reversible ISG15 modification of most target
proteins are still largely unknown [8,9].
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A strong induction of ISG15 in response to IFN treat-
ment or viral infections implies an antiviral role for
ISG15, yet surprisingly initial studies using vesicular sto-
matitis virus (VSV) and lymphocytic choriomeningitis
virus (LCMV) demonstrated that ISG15 or UBE1L are
dispensable for anti-viral immune responses in mice
[10,11]. Nevertheless, more emerging work has shown
that ISG15 plays an antiviral role against many viral
pathogens in vitro and in vivo, including influenza A/B,
herpes simplex virus type 1, murine gamma herpes
virus, HIV and etc. [12-18]. ISG15 achieves its antiviral
role by conjugating to target proteins including both
host proteins and viral proteins and altering their func-
tions. For example, ISG15 can conjugate to host anti-
viral protein IRF3 and thus stabilize IRF3 by inhibiting
its interaction with PIN1, a protein that promotes IRF3
ubiquitination and degradation [19]. ISG15 was also
found to modify the influenza A non-structural protein
NS1A, and inhibit its immunosuppressive function [15].
Little work has been done on the physiological relevan-
cies of ISG15 to flavivirus infections [14,20]. Surprisingly
though, a recent study even showed that ISG15 is favor-
able of hepatitis C virus infection [21]. It is though not
clear why ISG15 “likes” some viruses, but “dislikes”
some others, it is imperative to understand ISG15 func-
tion case-by-case. We hereby investigated the physiolo-
gical role of ISG15 in DENV and WNV infection in a
mouse macrophage cell line.
Isg15 is upregulated upon DENV or WNV infection
Mouse macrophage-like cell line RAW264.7 can be effi-
ciently infected by DENV and WNV, and is an estab-
lished in vitro model for the study of host innate
immune response to these viruses. By using a quantita-
tive PCR based small cDNA array (SABiosciences, Fre-
derick, MD), we measured the expression of Jak-Stat
signaling pathway related genes in DENV (DENV 2 New
Guinea C strain) or WNV (NY99 strain) infected
RAW264.7 cells. A number of genes were found up- or
down-regulated upon virus infection (Additional File 1).
Among them, Isg15 was upregulated 9-fold in DENV
infected cells, and 69-fold in WNV infected cells com-
pared with non-infected controls (Additional File 1). An
independent quantitative PCR (Figure 1) further con-
firmed the upregulation (6.5-fold and 11.5-fold, respec-
tively upon DENV or WNV infection) of Isg15
indentified from PCR array.
Isg15 activities repress DENV and WNV infection in
RAW264.7 cells
To study the specific role of Isg15 in DENV and WNV
infection, a siRNA based RNA interference study was
performed in RAW264.7 cells. siRNAs specific for gene
Isg15, Socs1, Socs3 from Jak-Stat pathway (Table 1) or
scrambled control (N.C.) were delivered into RAW264.7
cells respectively via electroporation (Socs1 and Socs3,
negative regulators of Jak-Stat signaling were included
as controls in this study). 24 hrs after siRNA transfec-
tion, cells were challenged by DENV (MOI = 1.0) or
WNV (MOI = 1.0) for another 24 hrs, respectively. Cells
were then harvested and total RNA and cDNA were
made according to standard protocols. The genes were
silenced efficiently (Figure 2A) as analyzed by quantita-
tive PCR using gene specific primers (Table 1); the
expression of Isg15, Socs1 and Socs3 were decreased 97,
59 and 24-fold, respectively, upon specific siRNA treat-
ment (Figure 2A). The intracellular viral loads, in terms
of the transcript levels of the envelop gene (E), were
quantified by quantitative PCR and normalized to
mouse beta actin gene. As shown in Figure 2B and 2C,
the DENV load was increased 2.1-fold (p < 0.05) and
WNV load increased 2.4-fold (p < 0.05) in Isg15 silenced
cells, respectively, compared with control cells. These
data suggest that Isg15 has an anti-viral activity against
both DENV and WNV in murine macrophage-like cells.
Furthermore, WNV burden was significantly decreased
in Socs1 (2.0-fold) or Socs3 (1.8-fold) silenced cells com-
pared to controls (Figure 2C) and a trend of reduction
in DENV burden was also found in Socs1/3 silenced
cells (Figure 2B). These results suggest that the Jak-Stat
pathway controls DENV and WNV infection in
RAW264.7 cells. Silencing the negative regulators of
Jak-Stat pathway, Socs1 or Socs3, resulted in an
increased Jak-Stat activity and decreased viral replica-
tion. On the other hand, viral replication was increased
Figure 1 Isg15 is upregulated upon DENV (A) or WNV (B)
infection. The virus burdens were analyzed by measuring the virus
E gene copy using quantitative RT-PCR, and normalized to mouse
beta actin gene. Results are expressed as the mean + the SEM. * p
< 0.05 and ** p < 0.01. Representative results from at least 3
independent experiments.
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Table 1 siRNA and oligo-primer sequences for this study:
No. Sequence (5’-3’) Note
1 CAGUGAUGCUAGUGGUACAtt siRNA seq for mouse gene Isg15
2 GCAUCCCUCUUAACCCGGtt siRNA seq for mouse gene Socs1
3 GCAUCUUUGUCGGAAGACUtt siRNA seq for mouse gene Socs3
4 AGAGGGAAATCGTGCGTGAC Forward primer for Quantitative-PCR of mouse beta-actin
5 CAATAGTGATGACCTGGCCGT Reverse primer for Quantitative-PCR of mouse beta-actin
6 CATTCCAAGTGAGAATCTCTTTGTCA Forward primer for Quantitative-PCR of DENV E gene
7 CAGATCTCTGATGAATAACCAACG Reverse primer for Quantitative-PCR of DENV E gene
8 TTCTCGAAGGCGACAGCTG Forward primer for Quantitative-PCR of WNV E gene
9 CCGCCTCCATATTCATCATC Reverse primer for Quantitative-PCR of WNV E gene
10 GGAACGAAAGGGGCCACAGCA Forward primer for Quantitative-PCR of mouse Isg15 gene
11 CCTCCATGGGCCTTCCCTCGA Reverse primer for Quantitative-PCR of mouse Isg15 gene
12 GCCGCAGCATTAAGTGGGGGC Forward primer for Quantitative-PCR of mouse Socs1 gene
13 GGTCTCCAGCCAGAAGTGGGAGG Reverse primer for Quantitative-PCR of mouse Socs1 gene
14 TGAGCCATCTTGGAGCCCAGGT Forward primer for Quantitative-PCR of mouse Socs3 gene
15 TTGGCTGTGTTTGGCTCCTTGTGT Reverse primer for Quantitative-PCR of mouse Socs3 gene
Figure 2 The viral burden is increased in Isg15 silenced cells. A) RNAi efficiency of specific genes. The mRNA levels of a specific gene were
analyzed by Q-RT-PCR and normalized to mouse beta-actin gene. B and C) DENV (B) or WNV (C) burdens in RAW264.7 cells after RNAi silencing.
Results are expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01. Representative results from at least 3 independent experiments.
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when Isg15 was silenced. This finding confirmed an
anti-DENV/WNV role for Isg15 in an in vitro model.
Ifnb1 expression is upregulated when Isg15, Socs1 or
Socs3 is silenced
We further measured the expression of representative
type I interferon (Ifnb1) in these cells. In both DENV
and WNV infected cells, the Ifnb1 transcript levels were
higher (up to 2~3 fold) in Socs1 or Socs3 silenced
groups (Figure 3), which is consistent with their inhibi-
tory function on the Jak-Stat and other anti-viral path-
ways. Surprisingly, Ifnb1 expression was also
significantly increased in Isg15 silenced cells infected
with DENV (2.9-fold) and WNV (2.3-fold). It is not
clear how ISG15 impacts type I IFN expression in this
study though; one explanation is ISG15 could be an
inhibitor of type I IFN production. Alternatively, an
increase in ifnb1 expression is a result of secondary
effect of increased viral burden (Figure 3).
Protein ISGylation is enhanced in DENV infected cells
To further understand the antiviral mechanism of Isg15,
we analyzed protein ISGylation profiles of DENV
infected or non-infected RAW264.7 cells. The cDNA for
mouse Isg15 were cloned into pcDNA3.1-V5-His vector
and transfected into RAW264.7 cells. To create the
stable cell line, the cells were selected using G418 for 2
weeks, and verified by Western blotting using an anti-
V5 tagged antibody (Figure 4A). These cells were then
infected with DENV for 24 hrs with a MOI of 1.0.
ISG15-conjugated proteins were then purified from
DENV infected or non-infected cells by affinity chroma-
tography using an anti-V5 monoclonal antibody cross-
linked to protein A/G resin. Western blots show that
after DENV infection, the concentrations of ISG15-con-
jugated proteins were dramatically increased compared
to non-infected controls (Figure 4B), suggesting ISG15
inhibits viral replication by modifying viral or cellular
proteins. Similar results were observed with human
Figure 4 ISGylated protein profiles from DENV infected or non-
infected RAW264.7 cells. A) Western blots of V5-tagged ISG15 in
RAW 264.7 cells. B) Western blots of ISG15-conjugated proteins from
DENV infected or non-infected cells.
Figure 3 Ifnb1 expression in virus infected cells after gene silencing. Ifnb1 gene expression level was measured by quantitative RT-PCR and
normalized to mouse beta-actin gene. Results are expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01. Representative results from at
least 3 independent experiments.
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monocyte cell lines (K562) and mouse embryo fibroblast
cells (MEFs) (data not shown).
Protein modification by ubiquitin and ubiquitin-like
proteins, including ISG15, SUMO and Nedd8, Fat 10,
has been shown to be important for many cellular pro-
cesses, such as cell cycle, stress response and immune
response [4]. ISG15 has been shown to be upregulated
upon type I interferon stimulation, microbial infections
and tumor growth [4,5,22,23]. Expression of ISG15 is
reported to be controlled by transcriptional factors Stat,
NFkb, p53 and JNK [4]. These studies suggest that
ISG15 is generally a stress-responsive gene.
The role of ISG15 and its conjugation activity in viral
infections has been intensively studied recently, though
controversial results have been reported with different
viruses [4,7]. One study shows that Isg15 is largely dis-
pensable for the type I IFN-induced antiviral response
against VSV and LCMV in mice [10]. While some other
work indicate that Isg15-/- or Ube1L-/- (ISG15 E1) mice
are more susceptible to many viral infections, such as
influenza A/B, herpes simplex virus and SNV, than WT
mice [4]. ISG15 can modify a number of important anti-
viral proteins, including RIG-1, IRF3, MDA-5, Mx1,
PKR, STAT1 and JAK1, and potentially influence their
functions [4,19,24]. However, Functional consequences
of this reversible modification are still mysterious. For
examples, ISGylation of RIG-I negatively regulates RIG-I
signaling and leads to a reduction of IFN production
[24]; while ISGylation of IRF3 prevents the ubiquination
and degradation of IRF3 during DNV infection [19].
ISG15 can inhibit the ubiquitination of Gag and Tsg101
of HIV-1, disrupts their interaction, and prevents the
virus assembles [17], while ISG15 also promotes HCV
infection in an in vitro model [21]. Generally speaking,
ISGylation does not lead to degradation of target pro-
teins, in stead, ISGylation stabilizes the target proteins
by inhibiting their ubiquitination and degradation [4].
On the other hand, viruses may also block the anti-
viral activity of ISG15 [4]. For example, nario-viruses
and arterviruses encode ovarian-tumor (OTU)-domain
containing proteases, which can deconjugate ISG15.
Overexpression of OUT proteases antagonizes the anti-
viral effect of ISG15 [25].
Since ISG15 plays distinct role in different viral infec-
tion model, we use DENV and WNV to explore the
function of ISG15 in these two vector-borne RNA
viruses. Our results suggest that ISG15 has an antiviral
activity against these two flaviviruses. And the antiviral
activity of ISG15 likely relies on its protein-modifying
activity. Our results also confirmed the inhibitory effect
of Socs1 and Socs3, on antiviral mechanisms such as the
Jak-Stat pathway. Future directions would be character-
izing the target proteins of ISGylation during DENV or
WNV infection, and indentifying novel anti-flavivirus
molecules and/or new mechanisms mediated by ISGyla-
tion. These studies may significantly increase our knowl-
edge on the pathogenesis of flavivirus infection and
advance the development of novel therapeutics or drugs
against these life-threatening viruses.
Additional material
Additional file 1: The expression of Jak-Stat pathway related gene
during DENV or WNV infection. The expression of genes from Jak-Stat
signaling pathway were measured using a quantitative PCR based small
cDNA array (SABiosciences, Frederick, MD). A number of genes were
found up- or down-regulated upon DENV or WNV infection.
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